Institute for Pharmaceutical Research Saarbrucken

The Helmholtz-Zentrum für Infektionsforschung GmbH is planning to construct laboratory building for pharmaceutical research in Saarbrücken (HIPS). To the northeast of the campus of the University of the Federal State of Saar, a four-storey building will be erected without a basement and be used for laboratories and offices. The floor plan measures 56 by 38.5 m, and the building will have a total height of 21.5 m including a technical centre. Apart from the ground floor, the building has three further storeys with a similar floor plan. A fourth floor is set back and houses technical facilities. The storeys are 4.3 m high. On the ground floor, there is a further technical control room with a height of 5.9 m.

The building will be erected as a steel skeleton construction. The ceilings are designed as flat slabs resting on pillars for point-shaped support and on walls as well as girders and suspended beams for line-shaped support. The support grid is mainly 6.9 x 6 m. The ceilings are 30 cm thick and partially shaped with a camber in order to limit deformation. The building is braced by ceiling disks combined with stiffening walls distributed across the floor plan. The technical centre on level 4 is a steel construction. The building is further reinforced in tranverse direction by a steel frame and by wind bracing in the facade in longitudinal direction. An external air intake is attached to the northeastern face on ground level. In order to avoid distortions due to differential subsidence, both building segments are separated by a structural joint. The building is a massive construction with flat ceiling slabs and load-bearing walls.

Services Wenzel + Wenzel: Tendering, Award of contracts, Site Supervision

Client: Helmholtz-Zentrum für Infektionsforschung GmbH

Design: ARCHITEKTEN BDA RDS PARTNER, Rauh Damm Stiller Partner, Planungsgesellschaft mbH

Project data:
period of performance: 2013 – 2015
gross room volume: ca. 39,000 m³
gross floor area: ca. 8,600 m²
costs: ca. €20.4m